Keywords: bristol-myers, squibb, 1st-qtr, sales, profits, down, takeover
Bristol-Myers Squibb's 1st-qtr sales and profits down, as takeover talk continues
Article | 07 May 2007
Even though first-quarter 2007 turnover and earnings at US drug major Bristol-Myers Squibb were lower year-on-year, the results still beat analysts ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
